The drug manufacturer Biofarm registered a net profit of 69.9 million RON in the first nine months of the year, up 6% compared to the same period last year, according to a company statement.The turnover increased by 10%, reaching 229 million RON, compared to 209 million RON in 2022. EBITDa reached 81.6 million RON during the mentioned period.In the first nine months of 2023, Biofarm occupied the 2nd place in the CHC (Consumer Healthcare) segment, in terms of the number of units sold. In terms of value, the company consolidated its sales to the final consumer, recording an increase of over 15% compared to the first nine months of 2022, compared to the purchase price in pharmacies.according to the source, the therapeutic areas with the greatest absolute increase in value in the first nine months of the year, in which Biofarm is active, were cold & flu, pain, magnesium-based supplements, digestion and nasal decongestants. The Biofarm brands associated with these therapeutic areas registered increases in their stock market share."The continuous development of new products, constantly adapted to the constantly diversifying consumer needs, represents one of the growth pillars of the Biofarm company. The company is also the volume market leader in the reference categories of eight of its brands: Bixtonim, Colebil, Triferment, Sennalax, Extravalerianic, Carmol solution, Carbocit and Nervocalmin. This balanced mix between long-lived brands and innovation is a strong differentiator for the Biofarm portfolio, positioning the company among the most relevant players in the CHC category," the release states.Biofarm is one of the first Romanian producers of medicines and food supplements, with a tradition of over 100 years. Currently, Biofarm is one of the top 10 existing producers on the pharmaceutical market in Romania and has a product portfolio that covers 65 therapeutic areas.
Royal FrieslandCampina N.V. has reached an agreement to sell its operations in Romania, including the local brand Napolact and the production facilities in Cluj-Napoca and Târgu Mureș, to Bonafarm Group. The decision follows a strategic review of FrieslandCampina's activities in Romania and aligns with the company's strategy of focusing "on core markets, high value-added growth […]
Romanian PM Ilie Bolojan operates outside of the legal procedures when initiating consultations on a proposal for amending the legislation on the service pensions in the field of Justice, the Romanian Superior Council of Magistracy (CSM) said in a press release on July 30. ...
Romania is currently rebuilding its bilateral relations with the United States with the aim of rejoining the Visa Waiver program after the Trump administration removed it from the list of partner countries, according to foreign minister Oana Ţoiu. During an interview given on Wednesday, July 30, the minister noted that efforts are being made for […]
Justice Minister Radu Marinescu (Social Democratic Party) stated, in an intervention on Digi24, that the ministry he heads supports the special pension reform, proposed by Prime Minister Ilie Bolojan, but "the set of proposals communicated by the prime minister will...
Romania’s governing coalition agreed on July 30 to hold local elections for Bucharest Mayor in November, although the exact date has not yet been set, Ziarul Financiar reported. The mayoral seat became vacant after former mayor Nicuşor Dan won the presidential election in May. On the same day, president...
State-owned Romgaz (BVB: SNG) sold 2.52 billion cubic meters of natural gas from domestic production in the first six months of the year, 12.55% above the level of the same period in 2024, according to the operational report from the Bucharest Stock Exchange. The company's financial report will be published on August 14. Hydrocarbon production […]
